A retrospective study shows that influenza and Mycoplasma pneumoniae infections in children returned to pre-pandemic levels after COVID-19 restrictions were lifted.



RT’s Three Key Takeaways:

  1. Post-Pandemic Rebound: Respiratory infections in children returned to pre-pandemic levels following the relaxation of COVID-19 mitigation strategies such as mask wearing and school closures.
  2. Variable Pathogen Peaks: Influenza A infections reached their highest levels in March 2023, while Mycoplasma pneumoniae infections peaked later in November 2023.
  3. Enhanced Surveillance: Continued epidemiological monitoring is essential for healthcare systems to identify changing transmission patterns and optimize vaccination and infection prevention strategies.


Respiratory infections caused by influenza viruses and Mycoplasma pneumoniae (M pneumoniae) returned to pre-pandemic circulation patterns after COVID-19 restrictions were lifted, according to research published in Current Microbiology. The findings highlight the lasting impact of pandemic control measures on respiratory pathogen transmission and underscore the importance of continued surveillance in children.

Non-pharmaceutical interventions introduced during the COVID-19 pandemic, including mask wearing, school closures, social distancing, and enhanced hygiene practices, dramatically reduced the spread of many respiratory pathogens worldwide. However, less is known about how these infections have re-emerged following the relaxation of restrictions, particularly in pediatric populations.

Researchers analyzed electronic health records from children presenting with respiratory symptoms at a hospital in northwest China between January 2020 and December 2024. A total of 169,757 children underwent testing for influenza A (IAV) and influenza B (IBV), while 412,015 were tested for M pneumoniae antibodies.

Across the study period, investigators identified 16,042 influenza A infections, 3,728 influenza B infections, and 82,760 M pneumoniae infections. Detection rates differed significantly between years, reflecting the changing impact of pandemic control measures on respiratory pathogen circulation. During periods of strict COVID-19 restrictions, detection rates for IAV, IBV, and M pneumoniae remained consistently low.

Following the easing of public health measures, however, respiratory pathogens rapidly re-emerged. Influenza A infections peaked in March 2023, while M pneumoniae infections reached their highest levels in November 2023. The findings suggest that reduced circulation during the pandemic was followed by a substantial rebound once opportunities for transmission increased.

The study also found that infection rates differed significantly according to both age and season. Although influenza A and M pneumoniae largely returned to age-related and seasonal patterns similar to those observed during the pandemic period, influenza B demonstrated modest shifts in its epidemiological profile after restrictions were lifted. These findings indicate that while respiratory pathogens resumed circulation, individual organisms may respond differently to changes in population immunity and public health measures.

The authors concluded that influenza viruses and M pneumoniae have re-established epidemic circulation among children following the relaxation of COVID-19 restrictions. They suggested that ongoing epidemiological surveillance will be essential for identifying changing transmission patterns, anticipating seasonal outbreaks, and informing vaccination and infection prevention strategies. As respiratory pathogens continue to readjust to the post-pandemic environment, monitoring these trends may help healthcare systems better prepare for future epidemics and optimize pediatric respiratory disease control.



Reference:

Tang, J., He, W., Li, B. et al. Epidemic Pattern Changes in Influenza A and B and Mycoplasma pneumoniae Pediatric Respiratory Infections During and After the COVID-19 Pandemic Restrictions in Northwest China. Curr Microbiol 83, 470 (2026). https://doi.org/10.1007/s00284-026-05061-3 https://link.springer.com/article/10.1007/s00284-026-05061-3

This article was originally published by AMJ and was made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.